drugset / Trial / NCT00487903
Evaluation and Optimization of PB127 Myocardial Perfusion Echocardiography on Ultrasound Systems
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this clinical trial is to evaluate various commercially available ultrasound systems and to identify imaging parameters to be used with these systems (along with the contrast agent PB127) as well as to further evaluate the safety of PB127.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-03
- Completion
- 2008-03
Outcome
Outcome not reported
Stopped (Business): “Discontinued PB127 development program for business reasons”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PB127 | Diagnostic / imaging agent | 0.062 mg/kg | Intravenous |